tm logo
Trademark Search
IMMUNITYBIO

View On IC.GC.CA

IMMUNITYBIO
SEARCHED

on 29 Oct 2024

Last Applicant/ Owned by

NANTCELL, INC.

9920 Jefferson Blvd.Culver City CA 92032

US

Serial Number

2269057 filed on 01st Mar 2023

IMMUNITYBIO

Trademark usage description

pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer f Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, in the field of vaccines; pharmaceutical preparations for low-dose chemotherapies, low dose radiation therapies, and personalized neoepitope-targeted therapies for medical use for the treatment of human diseases, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biologics, namely, cell-derived preparations, pharmaceutical preparations for cell therapies, monoclonal antibodies, cytokines, immune modulators, pharmaceutical preparations for low-dose chemotherapy and low-dose radiation therapy, antibodies, fusion proteins, peptide and cytokine biologics, vaccines, pharmaceutical preparations for personalized neoepitope-based therapies and cell therapies, and natural killer cell derived preparations for clinical, medicinal, therapeutic, and veterinary purposes; kits for clinical, medicinal, therapeutic, and veterinary purposes featuring cell cultures, and reagents.

Classification kind code

12

Class [042]
Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases

Classification kind code

12

Class [044]
Medical services; medical information; providing medical information in the fields of immunotherapy via a website; providing medical information in the fields of human diseases, animal diseases, cancer, vaccines, autoimmune diseases, and infectious diseases via a website; providing information relating to pharmaceuticals, oncology, immune-oncology, immunotherapy, human diseases, animal diseases, cancer, vaccines, autoimmune diseases, infectious diseases, biologics, cells, and cell-derived preparations.

Classification kind code

12

Mark Details

Serial Number

2269057

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 29th Oct 2024		Search Recorded
Submitted for opposition 20
on 29th Oct 2024		Examiner's First Report
Submitted for opposition 223
on 29th Oct 2024		Total Provisional Refusal
Submitted for opposition 256
on 13th May 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 13th Jul 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 12th Jul 2023		Formalized
Submitted for opposition 1
on 12th Jul 2023		Created
Submitted for opposition 228
on 01st Mar 2023		International Registration
Submitted for opposition 30
on 01st Mar 2023		Filed